ESTIMATING THE EFFICIENCY OF THREE NATIONAL CANCER SCREENING PROGRAMMES USING THE POPULATION-BASED CANCER REGISTRY DATA IN SLOVENIA Vesna ZADNIK MD,

Slides:



Advertisements
Similar presentations
Cancer cases and deaths across the world and in the UK : October 2011 Incidence across regions There are big variations in cancer incidence across the.
Advertisements

Racial Misclassification of American Indians in the Oklahoma Central Cancer Registry Anne Bliss, MPH Interim Program Manager/Epidemiologist Oklahoma Central.
Spotlight on Colorectal Cancer Screening 1 1. Home Screening for Colon Cancer
Cancer in the Northwest Territories ( ) Highlights from the Northwest Territories Cancer Report March 2014.
Cancer Statistics 2013 A Presentation from the American Cancer Society
World Burden of Cancer Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009.
© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Cancer Worldwide September 2011.
Stage-specific survival of screen-detected versus clinically diagnosed colorectal cancer - evidence from the FOBT screening trials- Iris Lansdorp-Vogelaar.
Cancer Statistics 2013 A Presentation from the American Cancer Society
HSB examples from Finland Nea Malila Mass Screening Registry, Cancer Society of Finland and University of Tampere, Tampere School of Public Health.
Cancer Incidence and Mortality in Massachusetts, Bureau of Health Statistics, Research and Evaluation Massachusetts Department of Public Health.
FIRST TWO AND HALF YEAR OF NATIONAL SCREENING PROGRAM FOR COLORECTAL CANCERS IN REPUBLIC CROATIA Miroslava Katicic 1, Milan Kujundzic 2, Davor Stimac 3,
EPIB-591 Screening Jean-François Boivin 29 September
Kathrin Strasser-Weippl 1 st Medical Department Wilhelminen Hospital, Vienna Cancer Care in Europe.
INCIDENCE AND SURVIVAL TRENDS OF COLORECTAL CANCER FROM 2002 TO 2011 BE Ansa; E Alema-Mensah; MD Claridy; JQ Sheats; B Fontenot, and SA Smith Georgia Regents.
Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based fecal occult blood testing: a population-based controlled trial.
Colorectal Cancer Screening in Appalachia PA: a pilot intervention project William Curry, MD, MS Dept of Family & Community Medicine M.S.Hershey Medical.
 Subhendu De, Wonsuk Yoo Institute of Public and Preventative Health (IPPH), Georgia Regents University On Summer Public Health Scholars Program (SPHSP)
Joni Reynolds, RN-CNS, MSN Director of Public Health Programs Winnable Battles: Cancer in Colorado.
Comprehensive Cancer Alliance for Idaho Idaho’s Hit List CCAI General Meeting November 14, 2007 Chris Johnson, MPH Cancer Data Registry of Idaho.
Incorporating Multiple Evidence Sources for the Assessment of Breast Cancer Policies and Practices J. Jackson-Thompson, Gentry White, Missouri Cancer Registry,
Assessing Colorectal Cancer Screening in Appalachia PA William Curry, MD, MS Mark Dignan, PhD Gene Lengerich, VMD Alan Adelman, MD, MS.
Effect of process indicators on the episode sensitivity of mammography Tytti Sarkeala, MSc Finnish Cancer Registry Ahti Anttila Matti Hakama Irma Saarenmaa.
Breast cancer affects 1 in 8 women during their lives. 1 Population Statistics.
GEOGRAPHIC DISTRIBUTION OF BREAST CANCER IN MISSOURI, Faustine Williams, MS., MPH, Stephen Jeanetta, Ph.D. Department of Rural Sociology, Division.
Lots of funny looking graphs. Age distribution Dependency ratio: number of people who are too young/old to work compared to the number of productive.
BC Cancer Agency CARE & RESEARCH Breast Cancer Mortality After Screening Mammography in British Columbia Women Andrew J. Coldman, Ph.D. Norm Phillips,
Colorectal Cancer Screening Implementation of a public health programme An Expert Group on Colorectal Cancer Screening Cancer Society of Finland, Finnish.
First results of a pilot population-based faecal occult blood colorectal cancer screening program B. DENIS, P. PERRIN, J.F. EBELIN, P. WEBER, E. KALTENBACH,
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
Cancer in Ontario: Overview A Statistical Report.
Developed from information included in the AIHW report Cancer in Australia: in brief 2014 Highlights.
BREAST CANCER BY STAGE OF DISEASE AT DIAGNOSIS, CENTRAL OKLAHOMA Arthur Owora, MPH; Aaron Wendelboe, PhD; David Thompson, PhD; Janis Campbell, PhD The.
1 Yize R. Wang, MD, PhD, John R. Cangemi, MD, Edward V. Loftus Jr, MD and Michael F. Picco, MD, PhD Am J Gastroenterol 2013;108:444–449 F1 김혁 / Prof. 김효종.
Cervical cancer among Asian subgroups in California, Janet Bates, MD MPH California Cancer Registry NAACCR Annual Meeting Denver, Colorado June.
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal- Cancer Deaths N ENG J MED ;8 : Ann G. Zauber, Ph.D, Sidney J. Winawer,
For the EUROCHIP-3 project
Cancer prevention and early detection
Cancer prevention and early detection
What does the data tell us? Colorectal CANCER IN NEVADA
World Cancer Day 2017 We Can, I Can Do you know this?
بسم الله الرحمن الرحيم.
2 Incidence SABER This module presents statistics from Chapter 2: Incidence Ontario Cancer Statistics 2016 Chapter 2: Incidence.
The Burden of Colorectal Cancer in Arkansas
The Burden of Cancer in Kentucky (2000 – 2013)
Cervical Cancer in California
(2) - Department of Epidemiology and Population Health, and
Prepared by staff in Prevention and Cancer Control.
Evidence of a Program's Effectiveness in Improving Colorectal Cancer Screening Rates in Federally Qualified Health Centers Robert L. Stephens, PhD, MPH1;
Cancer screening PROF .MAZIN AL-HAWAZ.
It is estimated that almost 1
SAMPLE – Preliminary Results
Kathleen England Neville Calleja 20th October 2017
INCIDENCE.
Colorectal Natural History Model
Access and utilisation of cervical cancer screening services among four African immigrant communities in Finland: A qualitative study MERH, May 2018,
Estimated current cancer incidence
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Reporting in CRC screening
It is estimated that more than 1
National Cancer Statistics in Korea, 2015
The experience of Cervical Cancer
Task Force on Cervical Cancer Screening in Estonia
Heiko Pohl, Douglas J. Robertson 
Challenges in Evaluating Screening & Prevention Interventions
Trends in survival from metastatic lung cancer in California,
Excess Hazard in the Belgian Cancer Population
Colorectal cancer survival disparities in California
South Carolina Statewide Cancer Prevention & Control Program
Presentation transcript:

ESTIMATING THE EFFICIENCY OF THREE NATIONAL CANCER SCREENING PROGRAMMES USING THE POPULATION-BASED CANCER REGISTRY DATA IN SLOVENIA Vesna ZADNIK MD, PhD Slovenian Cancer Registry Institute of Oncology Ljubljana ww.slora.si/en www.onko-i.si/en/crs vzadnik@onko-i.si

BACKGROUND: SLOVENIA SLOVENIA App: 20,000 km2 2 million inhabitants

BACKGROUND: SLOVENIAN CANCER REGISTY General cancer registry Population-based Compulsory notification since 1950 PIN Follow-up through Central Population Registry Linkage to screening registries database

BACKGROUND: CERVICAL CANCER SCREENING ZORA started 2003 conventional cytology 3 years interval age 20–64 participation 72%

BACKGROUND: COLORECTAL CANCER SCREENING SVIT started 2009 immunochemical fecal occult blood test, follow up colonoscopy 2 years interval age 50–74 participation 62%

BACKGROUND: BREAST CANCER SCREENING DORA started 2008 in central region, countrywide in 2018 digital mammography 2 years interval age 50–69 participation 73%

METHODS SCR data: C53, C18-C20, C50 INCIDENCE TREND: APC (before/after screening) SCR data linked to screening registries: ATTENDANCE analysis of screened age groups NET SURVIVAL (screend/non-screened) RISK OF DYING (screend/non-screened) STAGE DISTRIBUTION (screend/non-screened) Incidence for CerC and CRC for all pts diagnosed in Slovenia from SP start. Stage distribution, net survival and hazard ratio (HR) of death for screen vs not screen detected cancers diagnosed with CerC, CRC and BC from 2011-2015 for all invited patients to the SPs

RESULTS: CERVICAL CANCER SCREENING incidence trend ZORA Fifteen years after ZORA started, the incidence of cervical cancer has decreased for more than 50%

RESULTS: CERVICAL CANCER SCREENING net survival ZORA 5-yeat net survival: SCREENED / NON-SCREENED 92.1% / 63.7% HR: SCREENED / NON-SCREENED 0.18 (0.11 – 0.28)

RESULTS: CERVICAL CANCER SCREENING stage distribution ZORA

RESULTS: COLORECTAL CANCER SCREENING incidence trend SVIT APC-males: 2001-2010: + 7.6% 2010-2015: - 5.2% APC-females: 2001-2010: + 3.9% 2010-2015: - 4.5%

RESULTS: COLORECTAL CANCER SCREENING net survival SVIT 5-yeat net survival: SCREENED / NON-SCREENED 88.4% / 57.1% HR: SCREENED / NON-SCREENED 0.26 (0.23-0.29)

RESULTS: COLORECTAL CANCER SCREENING stage distribution SVIT

BACKGROUND: BREAST CANCER SCREENING net survival DORA 5-yeat net survival: SCREENED / NON-SCREENED 100% / 89% HR: SCREENED / NON-SCREENED HR 0.17 (0.10-0.31).

BACKGROUND: BREAST CANCER SCREENING stage distribution DORA

CONCLUSIONS Slovenian population-based cancer registry database is adequate for estimating the efficiency of three national cancer screening programmes. Soon after the introduction of organised cancer screenings in Slovenia the two basic cancer burden indicators incidence and survival have improved dramatically. Pts with screen detected cancers are diagnosed in earlier stages and have lower probability to die from cancer. The two presented and many other cancer burden indicators reported by the PBCRs are (also in Slovenia) most important for planning and evaluation of national cancer screening programmes.